By Duncan Bridgeman
|
Friday 23rd May 2003 |
Text too small? |
The 17% lift in profit was in line with expectations, pushing Healthcare shares up another 5c to $10.75 at press time yesterday.
Chief executive Michael Daniell said the company was planning a number of
significant new product introductions, including sleeping masks, humidifier systems, breathing circuits and patient warmers.
The result included realised and unrealised foreign exchange gains of $23 million after tax.
Operating revenue for the company's core product range grew 17% in US dollar terms over the previous year.
Mr Daniell said the company expected a continuation of strong US dollar revenue growth.
Fisher & Paykel makes heated humidification products for use in respiratory care and treatment of obstructive sleep apnea (OSA), a condition that stops breathing during sleep.
No comments yet
CHI - Channel Infrastructure delivers solid FY25 financial result
February 27th Morning Report
TRU - Results Guidance FY2026
TRU - Results Guidance FY2026
MEE - Me Today announces six-month results to 31 December 2025
HGH - Heartland announces 1H2026 result
BRW - FY26 Half Year Results Announcement
February 25th Morning Report
Genesis completes NZ$100m Placement
MCY - Invests heavily in renewables; delivers strong performance